Work

Quantitative Benefit–Risk Assessment of P‐gp–Mediated Drug–Drug Interactions of Dabigatran Coadministered With Pharmacokinetic Enhancers in Patients With Renal Impairment

Year: 2020

Type: article

Source: Clinical Pharmacology & Therapeutics

DOI: 10.1002/cpt.2087

Authors: Karthik Lingineni, Nashid Farhan, Sarah Kim, Rodrigo Cristofoletti, Lori A. Gordon, Parag Kumar, Scott Penzak, Colleen Hadigan, Jomy M. George, Joshua D. Brown, Stephan Schmidt

Institutions: University of Florida, National Institutes of Health, National Institutes of Health Clinical Center, National Institute of Allergy and Infectious Diseases, University of Florida Health

Language: English

Topic: Pharmacogenetics and Drug Metabolism

Subfield: Pharmacology

Field: Pharmacology, Toxicology and Pharmaceutics

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W3092968229

FWCI: 1.545

Cites: 18

Cited by: 8

Related to: 10